logo

XBIO

Xenetic Biosciences·NASDAQ
--
--(--)
--
--(--)

XBIO fundamentals

Xenetic Biosciences (XBIO) released its earnings on Aug 12, 2025: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), missed estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 12, 2025

Earnings

EPS
Revenue

Revenue & Expenses

XBIO has released its 2025 Q4 earnings report, with revenue of 766.30K, reflecting a YoY change of 18.11%, and net profit of -579.08K, showing a YoY change of 45.09%. The Sankey diagram below clearly presents XBIO's revenue sources and cost distribution.

Key Indicators

Xenetic Biosciences (XBIO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Xenetic Biosciences (XBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Xenetic Biosciences (XBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Xenetic Biosciences (XBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Xenetic Biosciences (XBIO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Xenetic Biosciences (XBIO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield